Wednesday 27 July 2011

Monotramal




Monotramal may be available in the countries listed below.


Ingredient matches for Monotramal



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Monotramal in the following countries:


  • France

International Drug Name Search

Thursday 7 July 2011

Restoril


Restoril is a brand name of temazepam, approved by the FDA in the following formulation(s):


RESTORIL (temazepam - capsule; oral)



  • Manufacturer: MALLINCKRODT INC

    Approved Prior to Jan 1, 1982

    Strength(s): 15MG [AB], 30MG [RLD][AB]


  • Manufacturer: MALLINCKRODT INC

    Approval date: October 25, 1991

    Strength(s): 7.5MG [AB]


  • Manufacturer: MALLINCKRODT INC

    Approval date: November 2, 2004

    Strength(s): 22.5MG [AB]

Has a generic version of Restoril been approved?


Yes. The following products are equivalent to Restoril:


temazepam capsule; oral



  • Manufacturer: ACTAVIS ELIZABETH

    Approval date: August 7, 1987

    Strength(s): 15MG [AB], 30MG [AB]


  • Manufacturer: MUTUAL PHARM

    Approval date: September 8, 2009

    Strength(s): 7.5MG [AB]


  • Manufacturer: MUTUAL PHARM

    Approval date: September 14, 2009

    Strength(s): 22.5MG [AB]


  • Manufacturer: MYLAN

    Approval date: July 7, 1986

    Strength(s): 15MG [AB]


  • Manufacturer: MYLAN

    Approval date: July 10, 1986

    Strength(s): 30MG [AB]


  • Manufacturer: MYLAN

    Approval date: June 12, 2009

    Strength(s): 22.5MG [AB]


  • Manufacturer: MYLAN

    Approval date: May 21, 2010

    Strength(s): 7.5MG [AB]


  • Manufacturer: NOVEL LABS INC

    Approval date: April 21, 1987

    Strength(s): 15MG [AB], 30MG [AB]


  • Manufacturer: SANDOZ

    Approval date: January 12, 1988

    Strength(s): 15MG [AB], 30MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: May 21, 1993

    Strength(s): 15MG [AB], 30MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Restoril. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Restoril.

See also...

  • Restoril Consumer Information (Drugs.com)
  • Restoril Consumer Information (Wolters Kluwer)
  • Restoril Consumer Information (Cerner Multum)
  • Restoril Advanced Consumer Information (Micromedex)
  • Restoril AHFS DI Monographs (ASHP)
  • Temazepam Consumer Information (Drugs.com)
  • Temazepam Consumer Information (Wolters Kluwer)
  • Temazepam Consumer Information (Cerner Multum)
  • Temazepam Advanced Consumer Information (Micromedex)
  • Temazepam AHFS DI Monographs (ASHP)

Sunday 3 July 2011

Tri-Gynera




Tri-Gynera may be available in the countries listed below.


Ingredient matches for Tri-Gynera



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Tri-Gynera in the following countries:


  • Portugal

Gestodene

Gestodene is reported as an ingredient of Tri-Gynera in the following countries:


  • Portugal

International Drug Name Search

BMD





Dosage Form: FOR ANIMAL USE ONLY
BMD®

30 Granular A

Bacitracin Methylene Disalicylate

Type A Medicated Article

Antibacterial


For supplementing rations of swine, chickens, turkeys, pheasants, quail and feedlot beef cattle



Active drug ingredient


Each pound contains feed grade bacitracin methylene disalicylate equivalent to 30 grams bacitracin (Master Standard).



Composition


A dried precipitated fermentation product obtained by culturing B. licheniformis Tracy on media adapted for microbiological production of bacitracin; calcium carbonate.



For manufacturing medicated poultry and livestock feeds only



Mixing directions


Prepare an intermediate premix containing 5 grams per pound by mixing 1.0 lb of BMD 30 Granular A with 5.0 lbs of soybean meal or ground corn. Then add 0.8 to 50 lbs of intermediate premix per ton of finished feed.































































SpeciesGrams bacitracin per ton of feedIndications for Use
Growing/ finishing swine10 - 30For increased rate of weight gain and improved feed efficiency.

 
250For control of swine dysentery (bloody scours) associated with Treponema hyodysenteriae in pigs up to 250 lbs body weight. Feed 250 grams per ton of complete feed on premises with a history of swine dysentery, but where signs of the disease have not yet occurred or following an approved treatment of the disease condition.

 
 
The 250 g/ton level will provide 5 to 7 mg/lb in swine weighing 40 to 250 lbs.

 
 
CAUTION: Diagnosis should be confirmed by a veterinarian when results are not satisfactory. Feed containing an approved level of bacitracin methylene disalicylate should be the sole ration. 
Pregnant sows250For control of clostridial enteritis caused by C. perfringens in suckling piglets when fed to sows from 14 days before through 21 days after farrowing on premises with a history of clostridial scours.

 
CAUTION: Diagnosis should be confirmed by a veterinarian when results are not satisfactory. Feed containing an approved level of bacitracin methylene disalicylate should be the sole ration. 
Broiler and replacement chickens4 - 50For increased rate of weight gain and improved feed efficiency.

 
50As an aid in prevention of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin methylene disalicylate.

 
 
100 - 200As an aid in control of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin methylene disalicylate.

 
 
CAUTION: To control a necrotic enteritis outbreak, start medication at the first clinical signs of disease. The dosage range permitted provides for different levels based on severity of the infection. Consult a poultry diagnostic laboratory or pathologist to determine the diagnosis and advice regarding the optimal level of drug. Administer continuously for 5 - 7 days or as long as clinical signs persist, and then reduce medication to prevention level (50 g/ton). 
Laying hens10 - 25For increased egg production and improved feed efficiency during the first seven months of production.
Growing turkeys4 - 50For increased rate of weight gain and improved feed efficiency.

 
200As an aid in control of transmissible enteritis in growing turkeys complicated by organisms susceptible to bacitracin methylene disalicylate. 
Pheasants4 - 50For increased rate of weight gain and improved feed efficiency.
Quail5 - 20For increased rate of weight gain and improved feed efficiency in quail not over 5 weeks of age.

 
200For prevention of ulcerative enteritis in growing quail due to Clostridium colinum susceptible to bacitracin methylene disalicylate. Feed continuously as the sole ration. 
Feedlot beef cattlemg/head/day
70

(continuously)
For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle.

 
 
250

(5 days in 30)
For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle. 

Note: Where minimum levels are shown, increase the antibiotic concentration within approved range when necessary to fit the feeding program, and to ensure adequate levels of antibiotic in the complete ration.


Restricted Drug (California) - Use only as directed.

For Use in Animals Only.

For Use in Dry Feeds Only.

Not for Use in Liquid Medicated Feeds.


NADA 46-592, Approved by FDA



Marketed by

Alpharma, LLC

Bridgewater, New Jersey 08807


Net wt 50 LB (22.68 kg)



Trademarks registered

by Alpharma, LLC


099316 1008



PRINCIPAL DISPLAY PANEL-22.68 kg Bag Label


BMD®

30 Granular A


ALPHARMA


Bacitracin Methylene Disalicylate

Type A Medicated Article

Antibacterial


See mixing directions, claims, cautions

and warnings on back


Net wt 50 LB (22.68 kg)


ALPHARMA®










BMD 
bacitracin methylene disalicylate  granule










Product Information
Product TypeOTC TYPE A MEDICATED ARTICLE ANIMAL DRUGNDC Product Code (Source)46573-132
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Bacitracin Methylene Disalicylate (Bacitracin)Bacitracin Methylene Disalicylate30 g  in 0.45 kg






Inactive Ingredients
Ingredient NameStrength
Calcium Carbonate 


















Product Characteristics
ColorGRAY (Gray to Brown)Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
146573-132-0022.68 kg In 1 BAGNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NADANADA04659202/05/2011


Labeler - Alpharma, LLC. (070954094)
Revised: 02/2011Alpharma, LLC.